113 results
8-K
EX-10.2
LFCR
Lifecore Biomedical Inc
20 Mar 24
Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes
6:32pm
injury to the Company; (iii) unauthorized use or disclosure by the Participant of any proprietary information or trade secrets of the Company or any other
8-K
EX-10.3
LFCR
Lifecore Biomedical Inc
20 Mar 24
Lifecore Biomedical Concludes Strategic Evaluation Process, Announces Management Succession and Board Changes
6:32pm
, detrimental reliance, invasion of privacy, nonphysical injury, personal injury or sickness, or any other harm, wrongful or retaliatory discharge … not suffered or incurred any workplace injury in the course of Executive’s employment with the Company, other than any injury that was made the subject
8-K
EX-10.3
LFCR
Lifecore Biomedical Inc
5 Jan 24
Entry into a Material Definitive Agreement
4:09pm
a limit of USD [* * *] Bodily Injury/Property Damage Liability per occurrence and in the aggregate. 8.08 NEITHER PARTY SHALL BE LIABLE TO THE OTHER
8-K
EX-10.2
LFCR
Lifecore Biomedical Inc
22 May 23
New $150 million credit arrangements include six-year credit agreement and equipment sale and leaseback to replace existing term loan
9:57pm
to sue for past, present and future infringement or dilution of any of the foregoing or for any injury to goodwill, and (v) all Proceeds of the foregoing … of the covenants contained in this Section will cause irreparable injury to Collateral Agent, that Collateral Agent has no adequate remedy at law in respect
8-K
EX-10.6
ct3o9mlkso26zf0
22 May 23
New $150 million credit arrangements include six-year credit agreement and equipment sale and leaseback to replace existing term loan
9:57pm
8-K
EX-10.5
c5enwfbkb2ew1ha39hc
22 May 23
New $150 million credit arrangements include six-year credit agreement and equipment sale and leaseback to replace existing term loan
9:57pm
8-K
EX-10.1
kl9u335
22 May 23
New $150 million credit arrangements include six-year credit agreement and equipment sale and leaseback to replace existing term loan
9:57pm
8-K
EX-10.1
3wnwz2
10 Aug 22
Landec Corporation Reports Fourth Quarter and Full Fiscal Year 2022 Results
4:20pm
8-K
EX-10.1
pefz8giwu
15 Oct 21
Departure of Directors or Certain Officers
4:04pm
8-K
EX-10.1
r69fk5kip07cfzv
2 Jun 21
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
66c2 aws2zn2xtvua
8 Mar 21
Departure of Directors or Certain Officers
5:27pm
8-K
EX-10.1
xjkwv 7ck
2 Feb 21
Departure of Directors or Certain Officers
12:37pm
8-K
EX-10.1
0fnx 8r2r1ado19f
20 Jan 21
Landec Appoints New Chief Financial Officer
5:07pm
8-K
EX-10.3
mi4vjn726e4g8rd
5 Jan 21
Landec Corporation Announces Comprehensive Refinancing of Credit Facilities
3:00pm
8-K
EX-10.1
mok3sp 9rovjdpqu1l
5 Jan 21
Landec Corporation Announces Comprehensive Refinancing of Credit Facilities
3:00pm
8-K
EX-10.1
v0vmw0g
24 Aug 20
Landec Nominates Three New Members to its Board of Directors, Providing
8:25am